Aspirin Use to Prevent Morbidity and Mortality From Preeclampsia: Preventive Medication
An Update for This Topic is In Progress
LAST UPDATED: Feb 17, 2021
The Task Force keeps recommendations as current as possible by routinely updating existing recommendations and developing new recommendations. A multistep process is followed for each recommendation. The Task Force uses gold standard methods to review the evidence and is transparent at each step of the recommendation development process.
See Current Final Recommendation Statement for Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication (2014)
Draft Recommendation Statement
Tools
- Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia (Consumer Guide): Draft Recommendation | Link to File
Public Comments are Closed for this topic.